Neosporin + Pain Relief Dual Action Topical Antibiotic Ointment, 3 ct

Neosporin + Pain Relief Dual Action Topical Antibiotic Ointment, 3 ct

$16.29

Features:

  • First aid antibiotic and pain relieving ointment.
  • For home & on-the-go.
  • Soothes cuts, scrapes, and burns.
  • Includes: 1-Neosporin + Pain Relief Ointment (1 oz), 2-Neosporin + Pain Relief Ointment (0.5 oz).
Neosporin + Pain Relief Dual Action Topical Antibiotic Ointment, 3 ct

$16.29

Add to cart
  • Size Guide

    Size Guide

    SIZE CHEST WAIST HIPS
    XS 34 28 34
    S 36 30 36
    M 38 32 38
    L 40 34 40
    XL 42 36 42
    2XL 44 38 44
  • Delivery Return

    User Guide

    Please read the manual before use.

    1. Safety Warning

    2. Product details

    3. Clock Display

    4. Product quick use

  • Ask a Question

Free

Worldwide
Shopping

100%

Guaranteed
Satisfaction

30 Days

Guaranteed
Money Back

Description

Product Description

Product Details

Neosporin + Pain Relief Dual Action Antibiotic Ointment provides infection protection and helps soothe painful minor cuts, scrapes, and burns. Formulated for first aid wound care, the antibiotic ointment contains Bacitracin Zinc, Neomycin Sulfate and Polymyxin B Sulfate to help fight infection for 24 hours. The first aid topical ointment is also formulated with Pramoxine Hydrochloride to help soothe and reduce pain from minor wounds for maximum-strength relief.

  • Neosporin + Pain Relief Dual Action Topical Antibiotic Ointment
  • Includes: 1-Neosporin + Pain Relief Ointment (1 oz), 2-Neosporin + Pain Relief Ointment (0.5 oz)

More Information:

  • Topical antibiotic ointment provides 24-hour infection protection of minor wounds and helps to soothe and relieve pain with a maximum-strength, no-sting formula
  • The no-sting formula of this antibiotic ointment also contains the topical analgesic Pramoxine Hydrochloride for maximum-strength external relief of painful cuts and wounds
  • First aid topical antibiotic and pain relief ointment from the #1 Doctor Recommended Brand*

*IQVIA Survey Feb 2023.